Preclinical services for biopharmaceutical product development: base IDIQ
Active Indefinite Delivery Contract Awarded
- Contract number
- 75N93023D00010
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Preclinical services for biopharmaceutical product development Pre-Solicitation · 75N93022R00004 · Posted Nov 10, 2021
- Last date to order 44% complete
- IDV ceiling
- $30,000,000.00
- Maximum order
- $30,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to International Aids Vaccine Initiative Inc. to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. The potential value of the contract is $30 million with a performance period from January 2023 through September 2030.
Services will be delivered under five task areas: product development planning and evaluation, analytical assay development and product characterization, process development and related activities, CGMP manufacture and related activities, and regulatory activities and documentation. The contract aims to provide preclinical product development support for promising therapeutic candidates and diagnostics to treat or diagnose infectious diseases. This includes conducting studies to obtain data for additional funding, partnerships, and regulatory submissions to advance candidates through clinical trials. Performance will comply with all applicable safety and health provisions.
Quick answers
Who was awarded contract 75N93023D00010?
75N93023D00010 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 8, 2023.
How much is contract 75N93023D00010 worth?
75N93023D00010's own ceiling is $30,000,000. A single order can be worth up to $30,000,000.
Who can order from contract 75N93023D00010?
75N93023D00010 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93023D00010 competed?
The extent of competition for 75N93023D00010 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV